Literature DB >> 23483863

Current Consensus and Remaining Questions Regarding the Diagnosis and Treatment of Helicobacter pylori Infection.

William D Chey1.   

Abstract

Entities:  

Year:  2012        PMID: 23483863      PMCID: PMC3594963     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


× No keyword cloud information.
  11 in total

1.  Low efficacy of clarithromycin including sequential regimens for Helicobacter pylori infection.

Authors:  Abdurrahman Kadayifci; Ahmet Uygun; Guldem Kilciler; Murat Kantarcioglu; Muammer Kara; Ayhan Ozcan; Ozdes Emer
Journal:  Helicobacter       Date:  2012-04       Impact factor: 5.753

2.  Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.

Authors:  Peter Malfertheiner; Francis Megraud; Colm A O'Morain; John Atherton; Anthony T R Axon; Franco Bazzoli; Gian Franco Gensini; Javier P Gisbert; David Y Graham; Theodore Rokkas; Emad M El-Omar; Ernst J Kuipers
Journal:  Gut       Date:  2012-05       Impact factor: 23.059

Review 3.  Clinical practice. Helicobacter pylori infection.

Authors:  Kenneth E L McColl
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

4.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

5.  Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding.

Authors:  J P Gisbert; X Calvet; A Cosme; P Almela; F Feu; F Bory; S Santolaria; R Aznárez; M Castro; N Fernández; R García-Grávalos; A Benages; N Cañete; M Montoro; F Borda; A Pérez-Aisa; J M Piqué
Journal:  Am J Gastroenterol       Date:  2012-05-22       Impact factor: 10.864

6.  Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan.

Authors:  Feng-Woei Tsay; Hui-Hwa Tseng; Ping-I Hsu; Kai-Ming Wang; Ching-Chang Lee; Shiuh-Nan Chang; Huay-Min Wang; Hsien-Chung Yu; Wen-Chi Chen; Nan-Jing Peng; Kwok-Hung Lai; Deng-Chyang Wu
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

7.  14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.

Authors:  E Robert Greenberg; Garnet L Anderson; Douglas R Morgan; Javier Torres; William D Chey; Luis Eduardo Bravo; Ricardo L Dominguez; Catterina Ferreccio; Rolando Herrero; Eduardo C Lazcano-Ponce; María Mercedes Meza-Montenegro; Rodolfo Peña; Edgar M Peña; Eduardo Salazar-Martínez; Pelayo Correa; María Elena Martínez; Manuel Valdivieso; Gary E Goodman; John J Crowley; Laurence H Baker
Journal:  Lancet       Date:  2011-07-21       Impact factor: 79.321

8.  Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection.

Authors:  Hyuk Soon Choi; Hoon Jai Chun; Sang Hoon Park; Bora Keum; Yeon Seok Seo; Yong Sik Kim; Yoon-Tae Jeen; Soon Ho Um; Hong Sik Lee; Chang Duck Kim; Ho Sang Ryu
Journal:  World J Gastroenterol       Date:  2012-05-21       Impact factor: 5.742

Review 9.  Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children.

Authors:  Luigi Gatta; Nimish Vakil; Gioacchino Leandro; Francesco Di Mario; Dino Vaira
Journal:  Am J Gastroenterol       Date:  2009-10-20       Impact factor: 10.864

10.  American College of Gastroenterology guideline on the management of Helicobacter pylori infection.

Authors:  William D Chey; Benjamin C Y Wong
Journal:  Am J Gastroenterol       Date:  2007-06-29       Impact factor: 10.864

View more
  3 in total

Review 1.  Vaccine against Helicobacter pylori: Inevitable approach.

Authors:  Amin Talebi Bezmin Abadi
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

2.  Upregulation of Vanilloid Receptor-1 in Functional Dyspepsia With or Without Helicobacter pylori Infection.

Authors:  Yoon Jin Choi; Nayoung Kim; Jinjoo Kim; Dong Ho Lee; Ji Hyun Park; Hyun Chae Jung
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

3.  The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients.

Authors:  Yalong Dang; Yalin Mu; Manli Zhao; Lin Li; Yaning Guo; Yu Zhu
Journal:  Ther Clin Risk Manag       Date:  2013-09-02       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.